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 DNA interstrand cross-links are a form of genomic damage that cause a block to 
replication and transcription of DNA in cells and cause lethality if unrepaired. Chemical 
agents that induce cross-links are particularly effective at inactivating rapidly dividing 
cells and, because of this, have been used to treat hyperproliferative skin disorders such 
as psoriasis as well as a variety of cancers. However, evidence for the removal of cross-
links from DNA as well as resistance to cross-link-based chemotherapy suggests the 
existence of a cellular repair mechanism. Characterizing the pathways involved in DNA 
interstrand cross-link repair has been challenging due to the inherent structure of the 
damage as it precludes the use of an undamaged, complementary strand of DNA as a 
template for repair.  
 A number of models of cross-link repair have been proposed based on the 
identification of hypersensitive repair mutants as well as biochemical evidence that 
specific repair enzymes are capable of incising cross-linked structures from DNA. 
Together, these models have suggested the involvement of multiple repair pathways—
such as nucleotide exicision repair, translesion synthesis, recombination of double-strand 
breaks, and base excision repair—operating in sequential steps to correct the damage. 
Most of the studies from which these models arose are complicated by the fact that cross-
linking agents induce multiple forms of damage or they lack in vivo confirmation of how 
the repair phenomenon occurs in organisms.  
 In this study, I use Escherichia coli as a model organism to examine the involvement 
of the aforementioned pathways in DNA interstrand cross-link repair in vivo. This 
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organism was useful in early cross-link studies and, with its highly conserved repair 
processes, maintains the potential for delineating how cross-links are removed in higher 
organisms. In Chapter I, I introduce background information on different cross-linking 
agents, the complications of studying cross-link repair, and the candidate repair pathways 
that have been implicated to date.  
 In Chapter II I demonstrate that there is a limited involvement of the nucleotide 
excision repair helicase, translesion polymerases, and double-strand break repair enzymes 
through survival analysis of cells defective in these proteins. For this analysis, I use 8-
methoxypsoralen plus UVA as a cross-linking agent and angelicin plus UVA as a 
monofunctional comparator. The observation that uvrD mutants—defective in helicase II 
of nucleotide excision repair—were nearly as resistant to 8-methoxypsoralen-induced 
damage as wild type cells led me to examine the incision rate of cross-links from 
endogenous plasmid DNA. Surprisingly, cross-links were not efficiently removed from 
DNA in uvrD mutants relative to wild type cells. These seemingly contradictory results 
were rectified when I quantified cross-link formation in cell cultures and revealed that as 
few as one cross-link per chromosome can inactive wild type cells, a lethal quantity that 
is lower than what has been previously reported. Taken together, these observations 
suggest that although cross-links are incised in wild type cells, repair is still not a highly 
productive event in E. coli.   
 In Chapter III I examine the involvement of the base excision repair pathway in cross-
link repair and demonstrate that Nth and Fpg Glycosylases, Xth and Nfo AP-
Endonucleases sensitize Escherichia coli to psoralen-induced DNA damage. This is 
shown by comparative survival analysis in angelicin plus UVA and 8-methoxypsoralen 
	 iii	
plus UVA treatment whereby nth-, fpg-, and xth-mutants are each more resistant than 
wild type cells to either treatment. This suggests that when these gene products are 
present they impact the production or removal of monoadducts. nfo-mutants were 
different in that the cells were only hyperresistant to 8-methoxypsoralen monoadducts 
and cross-links, either implying that the Nfo enzyme interacts specifically with psoralen 
monoadducts rather than angelicin monoadducts or that the enzyme impedes cross-link 
removal.  
 Finally, in Chapter IV a summary of the results is provided as well as future 
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Chapter I: Introduction 
 
 DNA interstrand cross-links form when chemicals covalently bind 
complementary strands of DNA. This type of damage obstructs necessary cellular 
processes such as replication and transcription and is lethal if left unrepaired. Knowledge 
of cross-linking agents came out of studies that examined the effects of mustard gas and 
nitrogen mustard employed during the World Wars (1, 2). It was observed that these 
compounds were particularly detrimental to actively dividing cells, such as those found in 
tumors of mice (3). This finding led to the use of nitrogen mustard as a chemotherapeutic 
in humans years before the actual mechanism of action was determined to be cross-
linking of DNA (3–5). Interestingly, secondary malignancies can arise from the use of 
cross-linking agents in chemotherapy (6, 7). For most, this risk following treatment does 
not outweigh the benefit. However, for a small population cross-linking agents cannot be 
repaired and therefore treatment itself can be lethal.  
 The population that this risk applies to is those afflicted with Fanconi anemia, a 
rare genetic disorder characterized by bone marrow failure, high susceptibility to acute 
myeloid leukemia, and diminished capacity for cross-link repair (8, 9). One method of 
diagnosing this disorder involves a chromosome breakage test in which a blood sample is 
treated with a cross-linking agent and then 72 hours later chromosomes at metaphase are 
examined (10, 11). A positive result is indicated by major chromosomal aberrations, 
which are consequences of cells that lack the gene products necessary to repair cross-
links (12).  
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 To date, 21 genes have been associated with the Fanconi anemia pathway (13), 
yet a complete understanding of how these gene products operate in healthy cells is still 
being delineated. The proteins identified in this pathway have been characterized by their 
involvement with the monoubiquitination of a heterodimer complex formed by proteins 
FANCD2 and FANCI. As such, there are proteins that comprise a core ubiquitin ligase 
complex responsible for monoubiquitination of FANCI/D2 and proteins that are recruited 
by this unbiquitinated heterodimer and act downstream to unhook cross-links from DNA 
and restore the damaged DNA site (13, 14). The majority of those diagnosed with 
Fanconi anemia have mutations in the core ubiquitin ligase complex (15), however, genes 
associated with this pathway are still being identified (16) and the overall repair 
mechanism of cross-links in humans is only partially understood.  
 
DNA interstrand cross-linking agents 
 While there is considerable evidence for the removal of cross-links from DNA in 
cells, how this form of damage is precisely repaired has remained challenging to 
characterize. One problem with identifying a repair mechanism is that chemical agents 
that form cross-links each have different binding (Figure 1.1) and structural effects on 
DNA. For example, nitrogen mustard binds to guanine bases in 5’-GNC sequences and 
severely distorts the beta structure of the DNA helix (17–20). Cisplatin preferentially 
binds guanines in 5’-GC substrates and induces a major bend and minor unwinding in the 
helical DNA structure. By comparison, mitomycin C binds to guanines in 5’-CG 
sequences but does not significantly distort the helix (21–23). Psoralen—the cross-
linking agent that is the focus of this study—binds to thymines at 5’-TA sites and only 
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modestly distorts DNA upon intercalation and binding (24, 25). If cellular recognition of 
damage is a prerequisite to repair then it may be the case that distinct repair pathways 
operate on cross-links to remove the various structures formed by different cross-linking 
agents. Indeed, in vitro studies have reported the involvement of different repair proteins 
and pathways for different agents (26) (27).   
   
Figure 1.1. DNA interstrand cross-linking agents covalently bound to their preferred 
DNA bases. A) Nitrogen mustard (yellow) binds to guanine bases in 5’-GNC sequences. 
B) Cisplatin (blue) binds to guanine bases in 5’-GC sequences. C) Mitomycin (red) C 
binds to guanine bases in 5’-CG sequences. D) Psoralen (green) binds to thymine bases in 
5’-TA sequences.  
 
 Another challenge to characterizing the mechanism by which cross-links are 
repaired is that all cross-linking agents induce multiple forms of damage, not just cross-
links (28). This is a result of cross-linking being a multi-step reaction: the chemical agent 
intercalates into DNA, covalently binds to a base, and then binds to a base on the 
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opposite strand of DNA. Therefore, monoadducts are produced as precursors to cross-
links but can persist as single-stranded damage when sequence context or structural 
properties preclude the second binding reaction (29, 30). Since cells treated with cross-
linking agents present a variety of monoadducts, cross-links, and potentially other forms 
of DNA damage, it is challenging to design experiments where the defect or phenotype 
can be specifically attributed to the presence or repair of the cross-link. One approach 
previously used to address this challenge has been to create site-specific cross-links in 
plasmids and study repair with purified repair proteins or extracts in vitro (31). While this 
method has provided insight in identifying gene products that are capable of binding to or 
incising cross-links, it largely remains unknown if these gene products operate on cross-
links similarly in vivo or contribute to the repair process of a living organism.  
 Since there are no agents that exclusively produce cross-links, a second approach 
to identifying cross-link-specific effects has been to compare monofunctional agents to 
related cross-linking agents (32–35). Psoralen has a variety of isomers that have been 
shown to vary in photo-reactivity with DNA. For example, Angelicin is a psoralen 
derivative that, due to its angular structure, only produces monoadducts with native DNA 
(36, 37). This isomer binds to the 5,6-double bond of thymine bases with the 3,4-double 
bond of its pyrone ring by way of UVA photoreaction (38) (Figure 1.2A). 8-
methoxypsoralen is another isomer of psoralen that is often used as the cross-linking 
agent alongside angelicin, since it produces a higher ratio of cross-links to monoadducts 
than that of psoralen (39). Like psoralen, the linear structure of this molecule allows for 
binding at the 4’,5’- and 3,4- positions of its furan and pyrone rings, respectively, to the 
5,6-double bonds of adjacent thymine bases (40, 41). There are four major products that 
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result from 8-methoxypsoralen plus UVA light and native DNA: two diasterometric 
furan-side monoadducts, one pyrone-side monoadduct, and one interstrand cross-link 
where the furan-side monoaddition necessarily precedes the pyrone-side addition (29, 42) 
(Figure 1.2B-E). 
 
Figure 1.2. Angelicin and 8-methoxypsoralen are furocoumarin isomers that intercalate 
in DNA and preferentially bind to thymine bases in photocycloaddition reactions. 8-
methoxypsoralen differs from angelicin in that it is linear in structure and has a methoxy 
group at the 8-position. A) Angelicin pyrone-side monoadduct. Angelicin reacts with a 
single UVA photon to form a pyrone-side cyclobutane ring (blue) with thymine. B) 8-
methoxypsoralen furan-side monoadduct. 8-methoxypsoralen reacts with a single UVA 
photon to form a furan-side cyclobutane ring (orange) with thymine. C) 8-
methoxypsoralen furan-side monoadduct (diastereomer of B). D) 8-methoxypsoralen 
pyrone-side monoadduct. 8-methoxypsoralen reacts with a single UVA photon to form a 
pyrone-side cyclobutane ring with thymine. E) 8-methoxypsoralen interstrand cross-link. 
Structure C is the only monoadduct product that can result in DNA interstrand cross-link 
product when reacted with an additional UVA photon and adjacent thymine base.  
 
 To effectively compare the effects and cellular responses of monofunctional 
psoralens with bifunctional psoralens it is important to standardize the doses to ensure 
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that comparable levels of damage are formed in each case. Using radioactively labeled 
psoralen and angelicin to quantify the respective levels of photoreaction of E. coli DNA, 
Borden et al. demonstrated that psorlen molecules photoreact with DNA about five times 
as frequently as angelicin molecules when drugs are used at equal concentration and cells 
are UVA-irradiated for 4-16 minutes (33). Additionally, some bifunctional psoralen 
isomers, such as 8-methoxypsoralen and amotosalen, produce different ratios of cross-
links and monoadducts in cells and this should be considered when comparing damage to 
angelicin-treated cells (43).  
 
DNA interstrand cross-link repair models 
 DNA damage occurs frequently in cells and is caused by both endogenous and 
exogenous agents. In most cases, damage is confined to a single strand or base of DNA 
and can be repaired faithfully by enzymes that utilize the undamaged complementary 
strand as a template for resynthesis following incision of the damaged strand (44). 
However, DNA interstrand cross-links covalently link complementary strands and 
complicate, in theory, how cells could accurately repair this form of damage.  A number 
of models have been proposed throughout the course of cross-link repair studies that each 
suggest the involvement of multiple repair pathways.  
 In early experiments in E. coli, the removal of bi-functional alkylation agents 
from DNA was detected by examining the alkylation products in E. coli DNA following 
treatment with 35S-labeled mustard gas via chromatographic analysis and suggested a 
possible cellular repair capacity for interstrand cross-links (45–47). Additionally, these 
studies demonstrated that a mutant strain incapable of removing thymine dimers from 
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DNA was likewise incapable of removing mustard gas lesions. In mammalian L-cells, 
Reid and Walker (48) also demonstrated via chromatographic analysis that excision of 
cross-linked DNA occurred and proposed a two-step process of unhooking the damage to 
remove the product.  
  As a follow up to these studies, Cole (49) was able to show in alkaline sucrose 
sedimentation profiles that the DNA from E. coli cells treated with a psoralen derivative 
and UVA light was cut into discrete pieces following incubation periods and that mutant 
recA- cells did not exhibit the same joining products. This evidence, coupled with 
alkaline CsCl density profiles that showed fragmented DNA was joined with DNA 
strands of higher molecular weight in recA+ cells treated with psoralen and UVA but not 
recA- cells, was interpreted to suggest that recombination events were involved in cross-
link repair. Thus one of the early models for repair proposed that incisions surrounding 
the cross-link on one strand of DNA by the nucleotide excision repair pathway are 
followed by a recombinational reaction that utilizes a homologous template to accurately 
resynthesize over the partially incised cross-link (49). Van Houten et al. later 
demonstrated in vitro that incubating a site-specific psoralen cross-link with purified 
UvrABC excision nucleases produces dual incisions on a single strand of DNA 
surrounding the cross-link (50). The UvrABC excinuclease complex operates in the 
nuclease excision repair pathway in prokaryotes and is associated with the removal of a 
diverse range of base damage and monoadducts (51, 52). The results from studies by 
Cole and Van Houten taken together strongly supported the idea that nucleotide excision 
repair promoted the primary incision step of cross-link removal and this model remains 
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prominent in the literature today. Be that as it may, the sequential repair events are still 
unclear.  
 In theory, after the initial incision event a cross-link would remain bound to the 
unincised DNA strand and prevent displacement of the damaged strand by helicases, such 
as UvrD. Similarly, a second round of excision repair operating directly on the incised 
region would lead to a double-strand break and result in a deletion of the sequences in the 
direct vicinity of the lesion. Thus, repair models invoked the idea that recombination may 
operate to recruit and provide an undamaged substrate that could be used as a template 
for the repair of this region. To examine how such a hypothetical substrate may be 
processed, Cheng et al. (53) used a biochemical approach involving a psoralen-
monoadducted oligomer that was incubated with RecA, paired with a homologous region 
in a plasmid, and then UVA irradiated to form a three-stranded complex with a site-
specific cross-link. This complex was incubated with dNTPs, radioactively labeled 
dCTPs, and proteins involved in the nucleotide exicison repair pathway—UvrA, UvrB, 
UvrC, helicase II, DNA polymerase I, and DNA ligase—and then samples were restricted 
and electrophoresed on native acrylamide gel to show that the three-stranded complex 
was a viable substrate following the initial incision repair process. These experiments 
contributed to the development of a cross-link repair model that includes nucleotide 
excision repair pathway coupled with recombination (Figure 1.3A). Interestingly, the 
helicase II—UvrD in E. coli—has yet to be analyzed for its involvement in cross-link 
repair in vivo.  The significant role UvrD plays in the turnover of UvrABC exinuclease 
complex during the repair of UV damage (54) makes the uvrD gene product an 
interesting candidate for repair role of interstand cross-link damage.   
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 An issue raised by critics of the initial model pointed out that should the cross-
link form in a region of the chromosome that has not yet been replicated no substrates for 
recombination would be available and faithful repair would not be possible. To address 
this, an alternative repair model was proposed and suggested that after initial incisions by 
the ABC excinuclease complex specialized translesion polymerases could replicate 
across the incised oligo-lesion product and provide a template for the second round of 
incisions (Figure 1.3B) (55). This idea was initially supported by a report that plasmids 
containing an interstrand cross-link displayed reduced survival when transformed into a 
polB- (polymerase II) mutant (56). Survival experiments in yeast cells demonstrated that 
rev3 mutants were sensitive to mitomycin C cross-links in stationary but not exponential 
phase (57), supporting the idea that an alternative repair pathway is involved when 
recombination products are not available as chromosome templates. Additionally, Zheng 
et al. observed mammalian cells that were defective in nucleotide excision repair and 
lesion bypass by PolH exhibited reduced repair of a site-specific mitomycin C cross-link 
in a reporter gene of a plasmid but that repair was complemented when transfected with a 
PolH expression vector (58).  However, the potential role for translesion synthesis during 
cross-link repair in vivo has not been systematically examine in bacteria.  
 Beyond the initial incisions of interstrand cross-links by the UvrABC 
excinuclease complex alternative models for repair completion have proposed that the 
process advances through a double-strand break intermediate (Figure 1.3C) (59–63). 
While exploring this possibility, Kitayama et al. demonstrated by sedimentation profiles 
on neutral sucrose gradients that D. radiodurans treated with mitomycin C exhibited 
double-strand break structures in DNA (64). Additional support for this intermediate 
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comes from mammalian studies, one of which detected the presence of double-strand 
breaks in DNA by running V79 cells treated with nitrogen mustard in plugs by pulse field 
gel electrophoresis (60). A potential role for double-strand break repair in the survival of 
cross-links has not been examined in E. coli.  
 In more recent studies with mammalian cells a number of base excision repair 
proteins have been shown to bind or incise interstrand cross-links (Figure 1.3D) and 
affect survival, although reports differ as to interpretation of the effects. An initial report 
found that in vitro, Endo VIII-like protein (NEIL1) could initiate repair on psoralen-
induced monoadducts or cross-links in DNA substrates mimicking those encountered 
during the second round of incisions (65). However, others have reported that NEIL1 
binding prevents the normal mechanism of incision and renders cells more resistant to 
interstrand cross-links when mutated (35, 66). Similarly, APE1—the primary AP 
endonuclease in mammalian cells—has been reported to impede the normal processing of 
cisplatin-induced cross-links, and could lead to cisplatin resistance when mutated (27, 
67). Finally, recent biochemical studies have suggested that NEIL3 promotes incision at 
psoralen interstrand cross-links and therefore promotes repair (26). However whether this 
occurs in vivo or affects cell survival was not determined.  
 Because most of these models lack in vivo evidence or characterization in 
bacterial cells, I have chosen to examine mutants from repair pathways previously 
implicated in order to determine which gene products are specifically involved in 
processing cross-links. In Chapter II I describe experiments using mutants from 
nucleotide excision repair, translesion synthesis, and double-strand break repair pathways 
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and Chapter III I discuss the possible involvement of base excision repair proteins. All 
results are summarized and conclusions are discussed in Chapter IV. 
 
Figure 1.3. Prominent models for repair of DNA interstrand cross-links. A) Nucleotide 
excision repair and homologous recombination. The interstrand cross-link (i) is initially 
incised by the nucleotide excision repair complex (ii) before the gap on the incised strand 
is filled in by recombination using a sister chromosome (iii). Nucleotide excision repair 
could then, in theory, make a second round of incisions on the opposing strand (iv), 
which would be filled in using the ‘newly formed’ complementary strand as a template 
(v) (adapted from (38, 49, 68)).  B) Nucleotide excision repair and translesion synthesis. 
The interstrand cross-link (i) is initially incised by the nucleotide excision repair complex 
(ii) before translesion synthesis filled in the gap (iii). Nucleotide excision repair then 
makes a second round of incisions to remove the lesion (iv) before the remaining gap is 
resynthesized using the ‘newly formed’ complementary strand as a template (v) (adapted 
from (55)). C) Excision-mediated double-strand break repair. Following an encounter 
with the replication fork (i), incision of the interstrand cross-link by nucleotide excision 
repair results in a double-strand break (ii). Translesion polymerases restore the incised 
template (iii) before a second round of nucleotide excision repair removes the cross-link 
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and restores the template (iv). Recombination then repairs the double-strand break to 
restore the replication fork (v) (adapted from (60–62)). D) Base excision repair. Two 
replication forks converge on a cross-link (i) and a glycosylase creates an abasic site on 
one side of the damage (ii). Translesion polymerases synthesize over the abasic site (iii) 
as well as the unhooked cross-link (iv) and then the remaining single-stranded damage on 
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Chapter II. Limited capacity or involvement of excision repair, double-strand breaks, or 
translesion synthesis for psoralen cross-link repair in Escherichia coli 
 
Abstract 
DNA interstrand cross-links are complex lesions that covalently bind complementary 
strands of DNA and whose mechanism of repair remains poorly understood. In 
Escherichia coli, several gene products have been proposed to be involved in cross-link 
repair based on the hypersensitivity of mutants to cross-linking agents. However, cross-
linking agents induce several forms of DNA damage, making it challenging to attribute 
mutant hypersensitivity specifically to interstrand cross-link damage. To address this, we 
compared the survival of UVA-irradiated mutants in the presence of 8-
methoxypsoralen—which forms interstrand cross-links and monoadducts—to that of 
angelicin—a congener forming only monoadducts. We show that incision by nucleotide 
excision repair is not required for resistance to interstrand cross-links. In addition, neither 
RecN nor DNA Polymerases II, IV, or V is required for interstrand cross-link survival, 
argument against models proposing that double-strand break intermediates or translesion 
polymerases participate in the repair process. Finally, estimates based on Southern 
analysis of DNA fragments in alkali agarose gels indicate that lethality occurs in wild 
type cells at doses producing as few as one interstrand cross-links per genome. These 





 DNA interstrand cross-links are highly cytotoxic lesions induced by a variety of 
bifunctional agents, including nitrogen mustard, cisplatin, mitomycin C, and psoralen 
plus UVA light (1–5). Cytotoxicity is thought to result from the covalent linkage between 
both DNA strands preventing strand separation and thus inhibiting essential processes 
like replication or transcription at these sites (2, 6). Cross-linking agents are widely used 
as chemotherapeutics and have been effectively employed in the treatment of a range of 
hyperplastic or dysplastic conditions such as psoriasis or white leprosy, respectively (7–
10). Their effectiveness in treating these disease states has led to an interest in 
understanding how these medically relevant lesions are processed by cells with the goal 
of developing novel targets or strategies for chemotherapeutics.  
 Although several genes have been isolated that, when mutated, render cells 
hypersensitive to cross-linking agents (11–13), many aspects of how these complex 
lesions are repaired and processed in cells remain unknown. Additionally, all cross-
linking agents induce multiple forms of DNA damage, making it difficult to attribute 
mutant hypersensitivity specifically to defective repair of the cross-link lesion (5, 14–17). 
Various models for interstrand cross-link repair have been proposed, each involving 
multiple repair pathways that couple components of nucleotide excision repair with 
recombination, translesion synthesis, or alternative nuclease complexes (18–21). 
However, after the initial incision event, all of these models remain highly speculative 
and are hampered by the challenges of reconstituting this multi-step, multi-pathway 
repair process.  
 Based on early experiments in E. coli, researchers recognized the challenge of 
repairing a DNA interstrand cross-link due to the covalent attachment of this adduct to 
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both DNA strands.  Researchers inferred that repair would likely require the sequential 
action of multiple pathways (12, 22, 23). The hypersensitivity of nucleotide excision 
repair and recombination mutants, uvrA and recA, respectively, suggested that nucleotide 
excision repair may initiate incisions on one strand and that recombination from a sister 
chromosome would then provide an undamaged template to replace the incised region. A 
second round of incisions by nucleotide excision repair could then complete the repair 
process. In support of this model, biochemical studies found that the UvrABC nucleotide 
excision repair complex would recognize and incise one strand of a cross-link in vitro 
(18). Other studies demonstrated that RecA could promote strand exchange at this site in 
vitro if the gapped region were first expanded through exonucleolytic degradation (24). 
Although the mechanisms suggested by this model could in principle repair a cross-link, 
it should be noted that uvrA and recA mutants are hypersensitive to almost all forms of 
DNA damage, not just cross-links. And currently, no intermediates for the events 
following the initial incision have been characterized or observed in vivo.  
 A feature common to most models to DNA interstrand cross-link repair is that the 
process is initiated by the nucleotide excision repair pathway—the primary pathway by 
which a diverse range of base damage and monoadducts are repaired (25, 26). In E. coli, 
UvrA, UvrB, and UvrC form an excinuclease that makes dual incisions surrounding a 
DNA lesion on the damage-containing strand (27). Cells deficient in any one of these 
gene products fail to make incisions and exhibit elevated levels of recombination, 
genomic rearrangements, and cell lethality (28–31). UvrD is a helicase that promotes 
removal of the incised oligo and releases the exinuclease complex from DNA before 
DNA polymerase I fills in the gap and DNA ligase seals the nick to complete repair (32–
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34). In the absence of UvrD the excinuclease complex remains bound to the initial adduct 
and cells are almost as hypersensitive and defective at removing lesions from the genome 
as those lacking UvrA, UvrB, or UvrC (35)(36). 
 Several in vitro studies suggest that nucleotide excision repair proteins act to 
initiate the processing of interstrand cross-links and in vivo studies have shown that uvrA, 
uvrB, and, uvrC mutants are hypersensitive to DNA interstrand cross-linking agents and 
fail to incise cross-links (18, 23, 24, 37–41). Cho, an alternative nuclease with homology 
to UvrC has also recently been shown to contribute to survival in the presence of 8-
methoxypsoralen, perhaps by enhancing the rate of the initial incision (41, 42). However, 
the role of UvrD in interstrand cross-link repair has not yet been examined in vivo. It has 
been postulated that UvrD may displace a cross-linked structure following the initial 
incision event by UvrABC complex so that the gap could be filled in by a translesion 
polymerase (18, 43). What complicates this is that UvrD is required for exinuclease 
turnover at monoadducts and turnover may still be required to allow further cross-link 
repair events to occur (34). It is possible that UvrD may also be required for strand 
displacement following the second round of incisions of an unhooked cross-link.  
 Other models noted that DNA cross-links occurring in nonreplicating cells or in 
unreplicated regions of the genome would not have a sister chromosome available for 
recombination (19, 44). To account for this, it was proposed that alternative DNA 
polymerases might replicate across the incised oligo-lesion product to provide a template 
for the second round of incisions. Support for this idea came from early reports that 
plasmids containing an interstrand cross-link displayed reduced survival when 
transformed into a pol B (Polymerase II) mutant (44). However, several labs have since 
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been unable to verify a range of phenotypes reported for this polB strain (44–46), 
implying the effect may have been to secondary mutation within this particular strain 
(47–49). A later biochemical study also showed that PolV, the dinB gene product, could 
synthesize through templates containing an unhooked oligo-bound cross-link in vitro, 
supporting the possibility that translesion synthesis could carry out this hypothetical step 
in cells (49). However, to date the potential role for translesion synthesis during cross-
link repair in vivo has not been systematically examined in bacteria.  
 A third model for the repair of cross-links comes from studies in mammalian cells 
and suggests that repair is coupled to replication and proceeds through a double-strand 
break intermediate (50–52). In this model, interstrand cross-links that block replication 
forks are incised by the Fanconi anemia pathway/nucleotide excision repair proteins 
(ERCC1/XPF endonuclease) as well as other structure-specific nucleases and result in 
double-strand break intermediates. Consistent with this, double-strand breaks are detected 
in both yeast and mammalian cells following treatment with interstrand cross-linking 
agents and double-strand repair mutants are hypersensitive to these drugs (50–52). 
Similarly, the bacterial UvrABC excinuclease has been shown capable of incising both 
strands of an interstrand cross-link in vitro (53, 54). However, whether double-strand 
breaks arise in vivo during the bacterial repair process has not been directly examined. 
 To further characterize the pathways and gene products involved in the repair of 
DNA interstrand cross-links, we compared the survival of E. coli cultures irradiated with 
UVA in the presence of 8-methoxypsoralen or angelicin. The comparison between these 
two isomers allows us to differentiate between genes products that are involved in the 
general repair of monoadducts from those that have a specific or concurrent role in cross-
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link repair (55).  8-methoxypsoralen is a linear molecule capable of forming DNA 
monoadducts and interstrand cross-links whereas angelicin has an angular structure that 
only allows it to produce monoadducts (4, 41, 56, 57). Using this approach, mutants 
lacking gene products that specifically contribute to the repair of interstrand cross-links 
would be expected to exhibit greater sensitivity to 8-methoxypsoralen-induced damage 
relative to angelicin-induced damage when compared to the sensitivity of wild type 
cultures (55). Here, we examined several candidate mutants from pathways that have 
been proposed to be involved in the repair of cross-links based on current models in 
bacteria or mammals.  
  
Methods 
Bacterial Strains. The parent strain used in this study is SR108, a thyA36 deoC2 
derivative of W3110 (58). Isogenic strains lacking uvrA (HL952), uvrD (CL1302), polB 
dinB umuDC (CL646) were constructed using standard P1 transduction methods that 
have been described previously (48, 59). CL912 (DY329 recN::cat) was constructed 
using the recombineering strain DY329 (60). The chloramphenicol resistance gene was 
amplified from TP507 (61) using PCR primers recNF-catF 
5’GTAATGGTTTTTCATACAGGAAAACGACTATGTTGGCACAATGAGACGTTG
ATCGGCAC, and recNR-catR 
5'GCAGGAAAAAAGTTTACGCTGCAAGCAGTTCTTTCGCATTCTTTCGAATTTC
TGCCATT. PCR product was then transformed into DY329 to generate CL912, selecting 
for chloramphenicol resistance. The gene replacement was transferred into SR108 using 
standard P1 transduction to generate CL915 (SR108 recN::cat). 
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Psoralen-UVA and Angelcin-UVA Survival Assays. Fresh overnight cultures were diluted 
1:100 in Davis medium (62) supplemented with 0.4% glucose, 0.2% Casamino Acids, 
and 10 µg/mL thymine (DGCthy) and grown at 37°C to an optical density of 0.4 at 
500nm (OD600). At this time, 10 µg/mL of 8-methoxypsoralen (Acros Organics, item 
298-81-7) or 40 µg/mL of angelicin (Sigma-Aldrich, item A0956) was added to the 
cultures and incubation continued for 10 min. Cells were then irradiated using two 32-
watt UVA bulbs (Sylvania) with a peak emittance of 320 nm at an incident dose of 6.3 
J/m2/s. Angelicin-treated cells were UVA-irradiated for longer time increments than 8-
methoxypsoralen-treated cells in order to achieve comparable kill curves for wild type 
cells in either condition. At the times indicated, 100-µL aliquots were removed from each 
culture and serially diluted in 10-fold increments. Triplicate 10-µL aliquots of each 
dilution were spotted on Luria-Bertani agar plates supplemented with 10 µg/mL thymine 
(LBthy) and incubated at 37°C. Viable colonies were counted the next day to determine 
the surviving fraction. The lethal dose in 8-methoxypsoralen-treated cultures was 
determined based on the Poisson expression, P(i) = xie-x/i!, as the fraction of surviving 
cells (those have zero lethal lesions) at a dose where cells in the population have an 
average of 1 lethal lesion; i = 0,  x = 1.  
 
In vivo detection of DNA interstrand cross-links. Cultures containing the plasmid 
pBR322 were grown overnight at 37°C in DGCthy medium supplemented with 50 µg/mL 
of ampicillin. A 0.1-mL aliquot from this culture was pelleted and resuspended in 10-mL 
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DGCthy medium without ampicillin and grown in a 37°C shaking water bath until grown 
to an OD600 of 0.4. 
 Cultures used for the incision/recovery assay were exposed to 20 µg/mL 8-
methoxypsoralen for 10 min at 37°C and subsequently irradiated with a UVA dose of 5.7 
kJ/m2. Irradiated cultures were then incubated for a recovery period of 120 min where 
0.75-mL aliquots were collected at times indicated and then transferred to an equal 
volume of ice-cold 4X NET buffer (10mM Tris [pH 8.0], 40mM EDTA, 400mM NaCl). 
 Cultures used for the dose-dependent induction of cross-links were exposed to 10 
µg/mL of 8-methoxypsoralen for 10 min at 37°C and UVA irradiated. Aliquots of 0.75-
mL were collected during the course of the UVA treatment at the doses indicated and 
transferred to an equal volume of ice-cold 4X NET buffer.  
 Cells were pelleted, resuspended in 130-µL lysis buffer (1 mg/mL lysozyme, 0.5 
mg/mL RNaseA in 10 mM Tris, 1 mM EDTA [pH 8.0]), and incubated at 37°C for 30 
min. Then, 10-µL of 10 mg/mL proteinase K and 10-µL of 20% Sarkosyl were added to 
the samples and incubation continued for 1 hour at 37°C. Samples were extracted with 
four volumes of phenol-chloroform, followed by two volumes of chloroform and then 
dialyzed against 200-mL of 1 mM Tris (pH 8.0) and 1 mM EDTA for 45 min using 47-
mm Millipore 0.025-µM pore disks. The DNA was digested with HindIII (Thermo 
Fisher) overnight at 37°C. Samples were electrophoresed on a 0.75% alkaline agarose gel 
in 30 mM NaOH, 1 mM EDTA at 1 V/cm for 16 hours. DNA in the gels was then 
transferred to Hybond N+ nylon membranes (GE Healthcare) using standard Southern 
blotting techniques. The plasmid DNA was detected by probing with 32P-labeled pBR322 
that was prepared by nick translation (Roche) using alpha 32P-dCTP > 6000Ci/mmol 
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(Perkin-Elmer). Southern blots were visualized using a Storm 840 phosphorimager (GE 
Biosciences) and its associated ImageQuant analysis software.  
 The fraction of 8-methoxypsoralen cross-links formed at each time point was 
calculated as the ratio of DNA band running at about twice the molecular weight of the 
linear band to the total DNA per lane and normalized to the fraction of cross-links in 
untreated samples. 
 Fraction of cross-linked plasmid = (XDtime(x)/TDtime(x)) – (XDuntreated/TDuntreated), 
where XD represents cross-linked DNA and TD represents total DNA.  
 The best-fit line for the fraction of lesion-free plasmid was calculated from the 
Poisson distribution based on the assumption that two photons must be absorbed to form 
a cross-link (40) (23) (63), where y = P(0) + P(1) = e-(m)x + (m)xe-(m)x. 
 
Results  
uvrD mutants are hypersensitive to monoadducts but are almost as resistant as wild 
type cells when both monoadducts and cross-links are present  
 To investigate the role of nucleotide excision repair enzyme UvrD in the 
processing of cross-links, we examined the survival of uvrD mutants following UVA 
irradiation in the presence of either 8-methoxypsoralen or angelicin. A previous study by 
Bordin et al. has shown that psoralen and angelicin photoreact with DNA in E. coli at a 
ratio of about 5:1 when irradiated with equal drug concentrations and doses of UVA light 
(56) whereas 8-methoxypsoralen forms adducts in native DNA at a ratio of about 4:1 
compared to angelicin (64). Therefore we chose to treat cells with 10 µg/mL 8-
methoxypsoralen or 40 µg/mL angelicin in order to induce a comparable number of 
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lesions in either treatment. Under these conditions, the survival of wild type cultures in 
the presence of angelicin was reduced by more than two orders of magnitude within 12 
kJ/m2 of UVA irradiation (Figure 2.1A). Alternatively, a loss of viability of the same 
magnitude was observed within 3 kJ/m2 in wild type cells treated with 8-
methoxypsroalen, consistent with the high lethality associated with the formation of DNA 
interstrand cross-links (Figure 2.1B). By comparison, uvrA mutants were hypersensitive 
to both angelicin and 8-methoxysproalen, with survival decreasing greater than two 
orders of magnitude after 1 kJ/m2 UVA irradiation in each case.  
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Figure 2.1. UvrD contributes to survival in the presence of monoadducts but not DNA 
interstrand cross-links. The survival of WT (Filled squares), uvrA (filled circles), and 
uvrD (open circles) mutants following UVA irradiation in the presence of A) 40 µg/mL 
angelicin or B) 10 µg/mL 8-methoxypsoralen is plotted. Plots represent the average of at 
least 4 experiments. Error bars represent standard error of the mean. 
 
 When we examined uvrD cultures under the same conditions, we observed that 
these mutants were nearly as hypersensitive to angelicin-induced monoadducts as uvrA 
mutants (Figure 2.1A), consistent with what has been observed for other forms of base 
damage and monoadducts such as pyrimidine dimers and N-acetoxy-N-
2acetylaminofluorene (65–67). However, uvrD mutants treated with 8-methoxypsoralen 
required over 2 kJ/m2 UVA irradiation to reduce survival by two orders of magnitude. At 
this dose, uvrD mutants exhibit a nearly wild type-like resistance. Two inferences can be 
made from this observation: First, the comparable resistance of wild type and uvrD 
mutants implies that UvrD does not contribute to interstrand cross-link repair. If the 
nucleotide excision repair complex initiates incisions at cross-links, one can infer that 
UvrD is not required for either oligo removal or excinuclease turnover during the first 
incision, nor would it be required if a second round of incisions occurs as postulated in 
many models such as those shown in Figure 1. Second, it is notable that uvrD mutants are 
hypersensitive in the presence of monoadducts (Figure 2.1A), but as resistant as wild type 
cells when both monoadducts and interstrand cross-links are present. This allows us to 
infer that the lethality observed in wild type cells is caused almost exclusively by the 
presence of DNA interstrand cross-links. Thus, although 8-methoxypsoralen 
monoadducts are formed at higher frequencies than interstrand cross-links, wild type 
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cultures are able to efficiently repair and survive in the presence of the former lesion and 
lethality results from the presence of interstrand cross-links.  
 The nearly normal resistance of uvrD mutants to interstrand cross-links might 
suggest that incision occurs normally in these mutants.  To examine this as a possibility, 
we compared the rate that interstrand cross-links were incised in wild type cells 
compared to uvrA and uvrD mutants. To this end, cultures containing pBR322 were 
treated with 8-methoxypsoralen and UVA light and then allowed to recover. At various 
times during the recovery period, total genomic and plasmid DNA was purified from 
aliquots of the cultures. The purified DNA was the restricted with HindIII to linearize the 
plasmid and examined by Southern analysis following alkali denaturing agarose gel 
electrophoresis to determine the rate that DNA interstrand cross-links were incised over 
time (Figure 2.2A). In wild type cultures immediately following 5.7 kJ/m2 of UVA 
irradiation, 3.6% of the plasmids contained a DNA interstrand cross-link. The fraction of 
DNA migrating in the cross-link region of the gel decreased over the recovery period, 
with more that three quarters of the cross-links being incised by the end of the 120-
minute time course (Figure 2.2B). In uvrA mutants, 7.9% of the molecules initially 
contained cross-links following UVA irradiation at the same dose. In these cultures, 
incisions of cross-links were severely impaired, as most cross-links persisted in the DNA 
throughout the 120-minute recovery period, consistent with previous studies showing 
defective incisions in these mutants. Surprisingly, although uvrD cultures are almost as 
resistant to cross-links as wild type cultures, the mutants were impaired in their ability to 
make incisions, similar to uvrA mutants. This observation implies that although 
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nucleotide excision repair proteins may be involved in the removal of cross-links, these 






Figure 2.2. uvrD mutants have diminished capacity for incising DNA interstrand cross-
links. A) Cultures containing the plasmid pBR322 were UVA-irradiated with 5.7 kJ/m2 in 
the presence of 20 µg/mL 8-methoxypsoralen and then allowed to recovery for 120-
minutes. To observe the cross-links remaining in the DNA at each time-point, total 
genomic and plasmid DNA was purified from cells, restricted with HindIII to linearize 
the plasmid, and examined by Southern analysis following alkali gel electrophoresis 
using 32P-labeled pBR322 as probe. B) The fraction of cross-links remaining in the DNA 
over the recovery period is plotted for WT (filled squares), uvrA (filled circles), and uvrD 
(open circles). The initial percentage of cross-linked plasmids immediately following 
UVA irradiation were as follows: WT, 3.6 ± 1.0%; uvrA, 7.9 ± 2.3%; and uvrD 6.6 ± 
0.7%. Plots represent the average of 7 experiments for WT and 4 experiments for uvrA 
and uvrD mutants. Error bars represent standard error of the mean.  
 
 
Translesion DNA polymerases do not contribute to survival in the presence of 
interstrand cross-links 
	 30	
 Following the initial incisions by nucleotide excision repair, models in both 
bacteria and mammals have proposed that translesion synthesis by alternative 
polymerases function to replicate across an incised oligo-cross-link intermediate to 
provide a template for the second round of incisions (20, 68, 69). Biochemically, Pol 
IV—the dinB gene product—is capable of synthesizing through templates containing an 
unhooked oligo-bound cross-link in vitro, supporting the possibility that translesion 
synthesis could carry out this hypothetical step (49). In mammals, several polymerases 
have been speculated to participate in cross-link repair based on mutant hypersensitivity 
to chemicals that form cross-links in addition to in vitro evidence for the ability of certain 
polymerases to synthesize past partially incised cross-links (69–73). However, the 
potential role for translesion polymerases during cross-link repair in vivo has not been 
examined in bacteria. To this end, the comparative survival of a mutant lacking all three 
translesion polymerases—Pol II, Pol IV, and Pol V—was examined following UVA 
irradiation the presence of angelicin or 8-methoxypsoralen. Relative to wild type cells, 
the absence of translesion polymerases rendered cells modestly sensitive to monoadducts 
formed by angelicin (Figure 2.3A). Comparatively, in the presence of both monoadducts 
and DNA interstrand cross-links, the sensitivity remained nearly identical (Figure 2.3B). 
The observation that the presence of DNA interstrand cross-links does not further 
sensitize the polymerase mutants beyond that seen in the presence of monoadducts alone 
implies that the translesion polymerases are not contributing to the survival of interstrand 
cross-links in vivo.  
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Figure 2.3. The transleison DNA polymerases do not contribute to survival in the 
presence of 8-methoxypsoralen-induced DNA interstrand cross-links. The survival of WT 
(filled squares), uvrA (filled circles), and polB dinB umuDC (open diamonds) mutants 
following UVA irradiation in the presence of A) 40 µg/mL angelicin or B) 10 µg/mL 8-
methoxypsoralen is plotted. Plots represent the average of at least 3 experiments. Error 
bars represent standard error of the mean. WT and uvrA from Figure 2.1 shown for 
comparison.  
 
Double-strand breaks are not a prominent intermediate in the repair of DNA 
interstrand cross-links 
 Several models for interstrand cross-link repair propose that repair proceeds 
through a double-strand break intermediate and requires recombination for repair to occur 
(50, 52–54, 74–78). Several genes in E. coli, when mutated, render cells hypersensitive to 
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double-strand breaks. However, most of these mutants, including recA, are hypersensitive 
to multiple forms of DNA damage. recN-mutants are unique in that they are 
hypersensitive to agents that generate double-strand breaks such as gamma irradiation, 
mitomycin C, nalidixic acid, or enzymatic restriction but are resistant to other forms of 
DNA damage that only induce single-strand lesions or monoadducts such as UV (79). 
Consistent with this role in repairing double-strand breaks, purified RecN binds and 
protects double-strand DNA ends and interacts with RecA to stimulate its ATPase 
activity and facilitate its loading at these damaged sites (80–82). If double-strand break 
intermediates form during the processing of interstrand-cross links, then one would 
expect recN mutants to be sensitive to 8-methoxypsoralen but not to angelicin. To 
examine this directly, we compared the survival of recN mutants after UVA irradiation in 
the presence of angelicin and 8-methoxypsoralen. As shown in Figure 2.4A, recN 
mutants were modestly sensitive to monoadducts formed in the presence of angelicin and 
UVA light when compared to wild type cultures. Cells lacking RecN were also modestly 
sensitive to 8-methoxyporalen treatment, however the degree of sensitivity of this strain 
relative to wild type cells was similar irrespective of the chemical agent used (Figure 
2.4B). The similar sensitivity of recN mutants and wild type cells in the presence of 
monoadducts alone or both monoadducts and cross-links suggests that recN is not 
contributing to survival in the presence of interstrand cross-links. By comparison, recA 
mutants were hypersensitive to treatments that produced cross-links and monoadducts as 
well as monoadducts alone (Figure 2.4).  
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Figure 2.4 RecN, which is required for resistance to double-strand breaks, does not 
contribute to survival in the presence of DNA interstrand cross-links. The survival of WT 
(filled squares), recA (filled triangles), and recN (open triangles) mutants following UVA 
irradiation in the presence of A) 40 µg/mL angelicin or B) 10 µg/mL 8-methoxypsoralen 
is plotted. Plots represent the average of at least 3 experiments. Error bars represent 
standard error of the mean. WT from Figure 2.1 shown for comparison. 
 
 
Repair of interstrand cross-links is inefficient in E. coli 
 The data presented in Figures 2.1-2.4 suggest that incisions by nucleotide excision 
repair, processing by double-strand break repair, or synthesis by translesion polymerases 
does not necessarily contribute to the survival of E. coli in the presence of interstrand 
cross-links. The survival results coupled with what we observed in the cross-link incision 
rate assay, prompted us to quantify the number of cross-links formed in vivo under the 
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conditions used in our survival analysis. To accomplish this, we examined cross-link 
formation as a function of UVA dose on pBR322, an endogenous plasmid in uvrA-
deficient cultures. Since uvrA mutants fail to incise cross-links efficiently (Figure 2.2), 
these lesions accumulate and persist on the plasmid and therefore can be directly 
quantified. To this end, cultures containing plasmid pBR322 were grown in media 
containing 10 µg/mL 8-methoxypsoralen and irradiated with increasing UVA doses. 
Total genomic and plasmid DNA was then purified and digested with HindIII to linearize 
the plasmid. The samples were electrophoresed in an alkaline denaturing agarose gel and 
Southern analysis was used to identify and quantify the cross-links formed at each UVA 
dose (41, 83). As shown in Figure 2.5A, cross-linked structures appear as the higher 
migrating species in the Southern blot relative to the single-stranded linear DNA band. 
The percent of cross-linked DNA at each UVA dose was calculated by dividing the area 
of cross-linked plasmid DNA over total DNA per lane and then subtracting the same ratio 
of the untreated lane. Then, the inverse of each data point was plotted as percent cross-
link-free plasmid as a function of UVA dose (Figure 2.5B) and the best-fit line was 
calculated under the assumption that DNA interstrand cross-links require absorption of 
two photons and, as demonstrated by a number of studies, form with second-order 
kinetics as a function of UVA dose (12, 23, 40).  
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Figure 2.5. One cross-link is sufficient to inactivate our parental strain of E. coli. A) 
Dose response of interstrand cross-link formation in vivo. uvrA mutants containing 
plasmid pBR322 were UVA-irradiated at the indicated dose in the presence of 10 µg/mL 
of 8-methoxypsoralen. DNA from cultures were the immediately purified and analyzed as 
in Figure 2.2 to observe the instrand cross-links formed at each dose. B) The percent of 
cross-link-free 4.3-kb plasmids remaining at each dose is plotted. The corresponding 
number of cross-links this represents per 4.6-Mb genome is also shown. Plots represent 
the average of 3 experiments. Error bars represent standard error of the mean. The best-fit 
line was calculated from the Poisson expression based on the assumption that absorption 
of 2-photon event is required to form an interstrand cross-link(40) (23) (63). The fraction 
of cross-link-free plasmids decreased at a rate of where y = P(0) + P(1) = e-(m)x + (m)xe-(m)x. 
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 Using this technique we are reasonably able to quantify cross-links when ~1% of 
the plasmids have at least one cross-link. Per the best-fit line in Figure 2.5B, this 1% 
detection limit corresponds to a minimum UVA dose of ~6.5 kJ/m2. Since we knew the 
size of plasmid pBR322—4,361 bp—and the percent of the plasmid population that had 
at least one cross-link, we were able to measure the number of cross-links induced at each 
UVA dose. We then applied this calculation to the E. coli genome— ~ 4.6 Mb—to 
estimate how many cross-links we were inducing per genome. A UVA dose of 6.5 kJ/m2 
corresponds to roughly 11 cross-links per/genome, however, this dose well exceeds the 
lethal dose in wild type cultures. Based on our analysis of wild type cultures, ~1.8 kJ/m2 
UVA irradiation was required to reduce survival to 37% (Figure 2.1B). This is the UVA 
dose at which cells in the culture, on average, incur one lethal lesion. Since this dose was 
below the limit of detection, we estimated the number of cross-links/genome based on an 
extrapolation of our dose response curve and found that this UVA dose corresponds to ~1 
cross-link in wild type cells. By this estimate, cells would lack or have an extremely 
inefficient system for repairing this form of damage. In uvrA mutants, lethality occurred 
at ~0.4 kJ/m2, which corresponds with approximately 0.04 cross-links per genome. This 
likely argues that uvrA mutants are killed by monoadducts before a cross-link is ever 
encountered in these cells. We infer from these results that E. coli may lack an effective, 
error-free mechanism for repairing interstrand cross-links. 
 
Discussion 
 We show that although uvrD mutants are hypersensitive to monoadducts, they are 
nearly as resistant as wild type cells in the presence of cross-links. The resistance of uvrD 
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mutants occurs despite their impaired ability to incise these lesions, similar to uvrA 
mutants. In vitro, it is well established that proteins from the nucleotide excision repair 
pathway are able to recognize and incise psoralen cross-links (18) and that mutants 
lacking these enzymes fail to incise cross-links and are hypersensitive to psoralen in vivo 
(18, 23, 24, 37, 38, 40, 41). This has led to the proposal in most current models that 
nucleotide excision repair initiates the removal of these lesion. However, nucleotide 
excision repair mutants are also hypersensitive to the presence of monoadducts. Psoralen, 
as with all cross-linking agents, induces monoadducts as well as cross-links which 
hampers the ability to determine whether nucleotide excision repair mutants are 
specifically sensitive to cross-links. The ratio of cross-links to monoadducts at a given 
UVA dose and 8-methoxypsoralen concentration varies depending on the cell line and 
further complicates in vivo studies using angelicin as a comparator (84–86). In the present 
study, we observed that the near wild type resistance of uvrD mutants occurs despite an 
inability to make incisions, demonstrating the UvrD does not contribute to the repair 
process and that incisions by nucleotide excision repair enzymes are not essential for 
resistance to psoralen-induced cross-links. These results imply that the incisions by 
nucleotide excision repair are not contributing to survival in the presence of interstrand 
cross-links.  
 We also tested other aspects of cross-link repair models including the presence of 
a double-strand break intermediate and the participation of translesion DNA polymerases. 
In both cases, we observed that mutants impaired for double-strand break repair or 
lacking the translesion DNA polymerases did not exhibit any specific hypersensitivity to 
cross-links beyond that observed when exposed to monoadducts alone. Furthermore, the 
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hypersensitivity of these mutants was relatively modest when either monoadducts alone 
or monoadducts and cross-links were present. Taken together, this results of this 
comparative analysis would argue that many of the proteins and pathways frequently 
proposed to participate in the repair process including nucleotide excision repair, double-
strand break repair, or translesion synthesis do not improve cell survival in the presence 
of these lesions.   
 The lack of contribution by these pathways led us to examine the cell’s overall 
repair capacity for interstrand cross-links. Our estimates, based on the differential 
mobility of cross-linked fragments in alkali agarose gels, suggests that doses which 
generate only 1 cross-link per genome are sufficient to inactivate our wild type strain. If 
these estimates are accurate, this would be consistent with our observations that neither 
nucleotide excision repair, double-strand break repair, nor translesion synthesis 
contributes to survival. Further, this would argue that E. coli lacks an efficient or 
effective mechanism for repairing this form of damage.  
 Early studies in the repair of cross-links in E. coli began with the assumption that 
an effective repair pathway is likely to exist (11, 12, 14, 22, 23, 38–40, 56, 57, 87, 88). 
This assumption has persisted in more recent work, including from our lab (41). Several 
of these studies have characterized the survival and recovery of cultures that were treated 
with psoralen plus UVA and some reported that repair mutants, such as recA and uvrA, 
were hypersensitive to psoralen and that incision intermediates appeared over time but 
were only re-joined in wild type cells. Although these observations were attributed to the 
formation and removal of interstrand cross-links, it seems likely that most of these 
phenotypes could also be attributed to a compromised ability to process monoadducts, 
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which are generated at higher frequencies and require these enzymes for repair. These 
studies were generally unable to differentiate between the cellular effects cause by 
monoadducts or cross-links, and this issue remains a challenge in present studies.  
 Angelicin and psoralen have previously been used in a comparative manner to 
study interstrand cross-link repair or recovery, as we have here, but these analyses were 
limited to comparing the overall toxicity and mutagenicity of monoadducts to cross-links 
(14, 56, 57) (89). Interestingly, in all cases, there was consensus that lethality was almost 
entirely attributed to the presence of cross-links, consistent with the general idea that the 
repair capacity of these lesions is limited. In one of the few studies that measured cross-
links directly, Lin et al. observed that the surviving fraction of psoralen plus UVA treated 
phage was always equivalent to the fraction of phage that remained cross-link free, 
consistent with the idea that cross-links cannot successfully be repaired (23).  
 Finally, based on our ability to detect cross-links using alkali agarose gels and 
Southern analysis, we estimated that only 1 lesion was sufficient to inactivate our wild 
type cells. Our limit of detection for cross-links in our assay was ~11 cross-links per 
chromosome and occurred at a dose well beyond the lethal dose for our wild type culture. 
Thus, if our method of quantifying cross-links is accurate, the ability of E. coli to repair 
these lesions is extremely limited. The only other estimate of cross-link repair capacity in 
E. coli comes from an early study by Cole (38) who reported that the AB1157 strain was 
capable of surviving treatments generating 67 cross-links. Cole stated that these estimates 
were derived from the elution pattern of single- and double-strand DNA from 
hydroxyapatite columns, but the data and methodology were not shown. Additionally, 
Cole inferred that cross-links formed at similar rates in UVA-irradiated cells as when 
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DNA was purified in solution and that cross-link formation increased linearly with UVA 
dose (90) (38, 91). Neither of these assumptions turned out to be correct and both would 
significantly over-estimate the number of cross-links at low UVA doses (92). Subsequent 
work from the group of Howard-Flanders questioned the accuracy of the hydroxyapatite 
method and used alkali sucrose gradient sedimentation to demonstrate that psoralen 
cross-links form with second-order kinetics, consistent with their required absorption of 
two photons (40) (23). Although the Howard-Flanders studies quantified psoralen-
induced cross-links and demonstrated a single cross-link was sufficient to inactivate 
phage lambda, they did not determine the lethal number of cross-links for the bacteria. A 
limitation in all previous studies, as well as the study presented here, is that current 
methods depend on extrapolation to determine the repair capacity of cells in culture since 
lethality occurs at doses below the limit of detecting these lesions directly. While the 
precise number of cross-links that can be repaired varies modestly between methods of 
estimation, it is clear that the repair capacity for these lesions is very limited. The limited 
capacity for wild type cells to repair and survive cross-links suggests 8-methoxysporalen 
plus UVA may be more comparable to treatments such as nalidixic acid or rifampicin. 
Unlike irradiation with UVC, when these drugs effectively target their respective 
essential cellular functions, cells lack true repair pathways for clearing this form of 
damage. Earlier work noted that while highly lethal overall, cells surviving cross-links 
contain high frequencies of deletions and point mutations that only appeared in 
nucleotide excision-proficient strains (40) (93), consistent with the idea that a significant 
portion of these repair attempts are not accurate. In mammalian cells, double-strand 
breaks are proposed to form predominantly following treatment with cross-linking agents 
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(75) (77) (78). It may be the case that the presence of double-strand end-joining activity 
and large proportion of noncoding DNA allow mammalian cells to survive inaccurate or 
deletion-prone repair events better than E. coli. This will be an addressable and important 
question to focus on in our future work.  
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Chapter III. Nth and Fpg Glycosylases, Xth and Nfo AP-Endonucleases sensitize 
Escherichia coli to psoralen-induced DNA damage 
 
Abstract 
In mammals, there are differing reports as to how base excision repair effects the removal 
and survival of cells in the presence of psoralen DNA interstrand cross-links.  Bacterial 
base excision repair proteins are highly conserved with their eukaryotic counterparts, 
however, the functional role of base excision repair during cross-link repair in bacteria 
has not been thoroughly examined.  To further characterize how this repair pathway 
contributes to interstrand cross-links repair, we compared the survival of UVA-irradiated 
mutants in the presence of 8-methoxypsoralen—which forms interstrand cross-links and 
monoadducts—to that of angelicin—a congener forming only monoadducts.  We show 
that inactivating either Fapy or Endo III glycosylases, or Exo III or Endo IV AP 
endonucleases confers a modest resistance to psoralen adducts.  With the exception of 
Endo IV, these enzymes sensitize cells to both angelicin and 8-methoxypsoralen.  
Further, we show that the absence of these enzymes did not detectably affect the rate that 
interstrand cross-links were incised or induced. However, their absence did reduce the 
rate that monoadducts appeared during UVA-irradiation.  Taken together, the results are 
most consistent with the idea that the base excision repair enzymes sensitize cells to 
psoralen agents, by impeding the formation or repair of the monoadduct species.  The 
glycosylases did not appear to contribute to survival, excision, or repair of the interstrand 




 DNA interstrand cross-links are a form of damage that covalently link 
complementary strands of DNA. Chemical agents that form cross-links are highly toxic 
and are widely used to treat cancer, vitiligo, and psoriasis (1) (2–4).  Interstrand-cross-
links prevent the separation of the two DNA strands and therefore represent an absolute 
block to the essential processes of replication and transcription, and is thought to be the 
primary cause of lethality in cells (5, 6). Psoralens—tricyclic compounds comprised of 
furan and pyrone rings—intercalate DNA to form noncovalent bonds. At 5'-TA 
sequences, absorption of UVA light results in a covalent bond between the furan or 
pyrone ring and thymine. If the furan-side monoadduct absorbs a second photon, covalent 
linkage between the remaining pyrone ring can occur with a second pyrimidine, resulting 
in a DNA interstrand cross-link (7, 8). Thus, psoralen-induced damage creates both 
monoadducts and DNA interstrand cross-links. However, based on studies using 
compounds or conditions that preferentially generate a single form of damage, disruption 
of metabolic processes and lethality is thought to result almost entirely from the cross-
link product (6, 9, 10).  The harmful nature of cross-link damage and the effective use of 
cross-linking agents in treating skin disease and some form of cancers has led to an 
interest in how these lesions are processed in cells. 
 The mechanism by which these lesions are repaired has been a challenge to 
address. In the case of monoadducts, the nucleotide excision repair pathway excises the 
damaged region of DNA and the complementary, undamaged strand can be used as a 
template to restore the excised region.  Alternatively, in the case of the cross-links the 
adduct remains attached to the complementary strand following excision, preventing the 
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completion of faithful repair.  To address this, several models have been proposed for the 
repair of interstrand cross-links, each involving the combined action of several repair 
pathways acting sequentially.  Most models propose that repair is initiated by nucleotide 
excision repair-catalyzed excision, and that either recombination or translesion synthesis 
then acts to restores the template of the incised region(11–14). In theory, a second round 
of nucleotide excision repair would then be able to complete the repair process. Other 
models suggest that incisions by nucleotide excision repair of both strands may lead to 
breaks that require double strand break repair pathways (15–17).   
 Despite these models, there is little evidence to support the idea that these 
pathways contribute to survival in the presence of interstrand cross-links exclusively.  
Nucleotide excision repair appears to recognize and incise cross-links both in vivo and in 
vitro (13, 18). However, in Chapter II of this manuscript we show that other nucleotide 
excision repair mutants, such as uvrD, fail to incise interstrand cross-links in vivo but 
remain nearly as resistant as wild type cells to interstrand cross-links. Similarly, mutants 
lacking translesion polymerases, or impaired for double strand break repair are no more 
hypersensitive to cross-linking agents than agents producing monoadducts alone, arguing 
that these pathways do not significantly contribute to survival in the presence of cross-
links. Furthermore, we also showed through direct calculations of a lethal dose of 
interstrand cross-links in E. coli that as few as 1 cross-link is sufficient to inactivate cells. 
Thus, it is possible that each of these pathways attempts to process these lesions but that 
their complexity prevents successful repair in cells and that multiple repair pathways 
cannot effectively operate sequentially as proposed in most models. While these 
observations may argue against an efficient mechanism for interstrand cross-link repair, 
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in humans cancer cells are known to develop resistance to cross-link based 
chemotherapeutics (19–21). This suggests the possibility that the normal repair pathways 
that interact inadequately with cross-links can be altered to process these lesions and 
therefore characterization of the mechanisms involved in typical interactions with cross-
linked DNA is of importance.   
 Base excision repair is one pathway that has recently garnered interest for its 
potential effects on cross-link repair.  There are conflicting reports as to the overall role 
of base excision repair in cross-link survival, with studies mostly in vertebrates 
suggesting that it can either promote or hinder repair.  Early studies proposed that a 
glycosylase acting to detach a cross-link from a substrate such as a stalled replication fork 
would represent a less dangerous lesion for the cell, as it would avoid an early break of 
the DNA backbone (22). In support of this, 3-methyladenine DNA glycosylase (Aag) was 
shown to protect against the clastogenic effects of MMC in murine embryonic stem cells, 
improving cell survival and decreasing sister chromatid exchanges(23). However, the 
same study found no effect when nitrogen mustard was used as a cross-linking agent, 
suggesting that the repair process was agent-specific.  Couvé et al. showed that purified 
Endo-VIII-like protein, NEIL1, was capable of incising psoralen-induced monoadducts 
from oligonucleotide duplexes, but not cross-links (24), leading the authors to speculate 
that base excision repair proteins may act at a late step in the repair pathway. They later 
confirmed that NEIL1 could initiate repair of psoralen cross-links on substrates 
mimicking those encountered during the second round of incisions on synthetic substrates 
in vitro and that mutations in this gene product sensitized cells to psoralen (25). In non-
small cell lung cancer cells, overexpression of APE1—the human apurinic/apyrimidinic 
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endonuclease—has been correlated cisplatin resistance, a cross-linking agent commonly 
used in chemotherapy (26). This would seem to imply that APE1 protects against 
lethality from cross-links.   
 Other studies suggest base excision repair impairs survival in the presence of 
cross-links. Loss of uracil DNA glycosylase (UNG) in primary mouse embryonic 
fibroblasts has been reported to confer cisplatin resistance (27). The authors demonstrated 
that, in vitro, cisplatin cross-links could lead to the preferential deamination of 
surrounding cytosines and that UNG may lead to detrimental breaks at these locations.  
McNeill et al. demonstrated that NEIL1 binds to trioxsalen cross-link substrates in vitro 
and that in LN428 cells NEIL1 slows recruitment of XPC, a protein required for global 
nucleotide excision repair (28). Finally, using Xenopus egg extracts, NEIL3 glycosylase 
has been found to be capable of incising psoralen but not cisplatin DNA cross-links on 
plasmids substrates (29). The authors propose that this may represent a mechanism that 
promotes repair of psoralen cross-links, however whether NEIL3 operates in this manner 
in vivo has not been examined. In vitro, several DNA glycosylases from both prokaryotes 
and eukaryotes have been shown to bind and/or incise both psoralen monoadducts and 
cross-links (25) (28, 30) (29) (31).  However, it is not clear whether these gene products 
act explicitly on cross-links or monoadducts in vivo.  
 Identifying genes that specifically process or affect survival of interstrand cross-
links has remained a challenge because all cross-linking agents induce multiple forms of 
damage (32–34) and most mutants that have been identified as hypersensitive to cross-
linking agents are also hypersensitive to chemicals producing monoadducts (9), making it 
difficult to attribute the mutant's hypersensitivity to the cross-link. Therefore, to 
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differentiate and identify gene products that are specifically involved in processing cross-
links, monoadducts, cross-links, or both, we compared the survival of E. coli cultures 
irradiated with UVA in the presence of 8-methoxypsoralen or angelicin.  The comparison 
between 8-methoxypsoralen and angelicin allowed us to differentiate between genes that 
are involved in the general repair of monoadducts from those that may have a specific 
role in interstrand cross-link repair (35).  8-methoxypsoralen forms DNA monoadducts 
and interstrand cross-links at different ratios depending on concentration of drug, dose of 
UVA light, and cell line (36) (37–39). Angelicin is a congener of psoralen whose angular 
structure renders its unable to form cross-links, producing almost entirely monoadducts 
(11, 40, 41) (42). Thus, the survival of mutants lacking gene products specific to 
processing interstrand cross-links would be expected to be distinct between 8-
methoxypsoralen and angelicin relative to wild type cultures. Here, we characterized 
several base excision repair mutants that have been proposed to be involved in psoralen 
cross-link processing based on previous biochemical studies in bacteria or their 
mammalian homologs.   
 
Methods 
Bacterial Strains. The parent strain used in this study is SR108, a thyA36 deoC2 
derivative of W3110(43, 44). Isogenic strains lacking uvrA (HL952), nei (CL1005), nth 
(CL1006), fpg (CL1009), and fpg nth nei (CL1938) were constructed using standard P1 
transduction methods and have been described previously (45, 46). Isogenic strains 
lacking nfo (CL1116) and nfi (CL1326) were made by standard P1 transduction of the 
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nfo-1::kan marker from BW540 and nfi-1::cat marker from BW1171 into SR108, 
respectively (47) (48). 
 CL1155 (DY329 xth::cat) was constructed using the recombineering strain 
DY329 (49). The chloramphenicol resistance gene was amplified from TP507 (50) using 
PCR primers xthF-catF, 
5’gtctcttttaatatcaacggcctgcgcgccagacctcacTGTGACGGAAGATCACTTCG, and xthR-
catR, 5’cggtttttccatgctgcggatttcatagtcgatgccggtACCAGCAATAGACATAAGCG. The 
PCR product was then transformed into DY329 to generate CL1155, selecting for 
chloramphenicol resistance. The gene replacement was transferred into SR108 using 
standard P1 transduction to generate the isogenic xth strain used in this study, CL1168. 
 
Psoralen-UVA and Angelicin-UVA Survival Assays. Fresh overnight cultures were diluted 
1:100 in 8-mL Davis medium (51) supplemented with 0.4% glucose, 0.2% Casamino 
Acids, and 10 µg/mL thymine (DGCthy) and grown at 37°C to an optical density of 0.4 at 
600 nm (OD600). At this time, 10 µg/mL of 8-methoxypsoralen or 40 µg/mL of angelicin 
was added to the cultures and incubation continued for 10 min. Angelicin-treated cells 
were UVA-irradiated for longer time increments than 8-methoxypsoralen-treated cells in 
order to achieve comparable kill curves for wild type cells in either condition. Cells were 
then irradiated using two 32-watt UVA bulbs (Sylvania) with a peak emittance of 320 nm 
at an incident dose of 6.3 J/m2/s. At the times indicated, 100-µL aliquots were removed 
from each culture and serially diluted in 10-fold increments. Triplicate 10-µl aliquots of 
each dilution were spotted onto Luria-Bertani agar plates supplemented with 10 µg/mL 
thymine (LBthy) and incubated at 37°C. Viable colonies were counted the next day to 
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determine the surviving fraction.  8-methoxypsoralen was purchased from Acros 
Organics (item 298-81-7, lot A0143457). Angelicin was purchased from Sigma-Aldrich 
(item A0956, lot 042M4054V).  
   
In vivo detection of DNA interstrand cross-links.  Cultures containing the plasmid 
pBR322 were grown overnight at 37°C in DGCthy medium supplemented with 50 µg/mL 
of ampicillin. A 0.1-mL aliquot from this culture was pelleted and resuspended in 10-mL 
DGCthy medium without ampicillin and grown in a 37°C shaking water bath to an 
OD600 of 0.4. At this time, cultures used for the incision/recovery assay were exposed to 
20 µg/mL 8-methoxypsoralen for 10 min at 37°C and subsequently irradiated with a 
UVA dose of 5.7 kJ/m2. Irradiated cultures were then incubated for a recovery period of 
120 min where 0.75-mL aliquots were collected at times indicated and then transferred to 
an equal volume of ice-cold 2X NET buffer (10mM Tris [pH 8.0], 40mM EDTA [pH 
8.0], 400mM NaCl). Cells were pelleted, resuspended in 130-µL lysis buffer (1 mg/ml 
lysozyme, 0.5 mg/mL RNaseA in 10 mM Tris, 1 mM EDTA [pH 8.0]), and incubated at 
37°C for 30 min. Then, 10-uL of 10 mg/mL proteinase K and 10-µL of 20% Sarkosyl 
were added to the samples, and incubation continued for 1 hour at 37°C. Samples were 
extracted with four volumes of phenol-chloroform, followed by two volumes of 
chloroform and then dialyzed against 200 ml of 1mM Tris (pH 8.0), 1mM EDTA (pH 
8.0) for 45 min using 47-mm Millipore 0.025-µm pore disks. The DNA was digested 
with HindIII (Thermo Fisher) overnight at 37°C. Samples were electrophoresed on a 
0.75% alkaline agarose gel in 30 mM NaOH, 1 mM EDTA at 1 V/cm for 16 hours. DNA 
in the gels was then transferred to Hybond N+ nylon membranes (GE Healthcare) using 
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standard Southern blotting techniques. The plasmid DNA was detected by probing with 
32P-labeled pBR322 that was prepared by nick translation (Roche) using alpha32P-dCTP 
>6000Ci/mmol (Perkin-Elmer). Southern blots were visualized using a Storm 840 
phosphorimager (GE Biosciences) and its associated ImageQuant analysis software.   
 The fraction of 8-methoxypsoralen cross-links formed at each time point was 
calculated as the ratio of DNA running at about twice the molecular weight of the linear 
band to the total DNA per lane and normalized to the fraction of cross-links in untreated 
samples.  
 
Fraction of cross-linked plasmid = (XDtime(x)/TDtime(x)) - (XDuntreated/TDuntreated), where XD 
represents cross-linked DNA and TD represents total DNA.  
 
Results 
 To examine how base excision repair affects survival in the presence of 8-
methoxypsoralen-induced DNA interstrand cross-links, we compared the survival of 
several glycosylase mutants following UVA irradiation in the presence of either 40 
µg/mL angelicin or 10 µg/mL 8-methoxypsoralen. In previous work, these concentrations 
of have been shown to form adducts in DNA at similar frequencies for a given dose of 
UVA (40, 52). Angelicin plus ~20 kJ/m2 UVA irradiation reduced survival of wild type 
cells by more than four orders of magnitude (Figure 3.1A).  By comparison, in the 
presence of 8-methoxypsoralen, a similar loss of viability was observed within 4 kJ/m2, 
with lethality (LD37) occurring at ~1.8 kJ/m2.  In Chapter II, we show that this dose 
represents only about 1 cross-link per chromosome, consistent with cross-links being 
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highly lethal lesions that lack an efficient mechanism of repair (53).  In mutants lacking 
either Endo V (nfi) or Endo VIII (nei), we found that the survival was similar to that of 
wild type cells in the presence of either angelicin or 8-methoxypsoralen (Figure 
3.1A&B), arguing against a role for these enzymes in processing psoralen-induced 
damage.  By comparison, in the absence of either Fapy (fpg) or Endo III (nth), cultures 
were modestly more resistant to UVA irradiation in the presence of either angelicin or 8-
methoxypsoralen compared to wild type cells (Figure 3.1).  The resistance conferred by 
deletion of fpg or nth in the presence of monoadducts was similar in magnitude to that 
seen with when both monoadducts and cross-links were present, arguing that these 
glycosylases are likely to sensitize cells to psoralen through interactions with the 
monoadducts, rather than cross-links.  
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Figure 3.1. Glycosylases Nei and Fpg and endonucleases Nfi and Nth are not required 
for 8-methoxysproalen-induced interstrand cross-link survival in E. coli. The survival of 
WT (closed squares), nei-(closed triangles), fpg-(open diamonds), nfi-(closed circles), 
and nth-(open circles)deficient cells following UVA irradiation in the presence of A) 40 
µg/mL angelicin or B) 10 µg/mL 8-methoxypsoralen. Angelicin produces monoadducts 
based on its angular structure (depicted above A) whereas 8-methoxypsoralen can 
produce both monoadducts and DNA interstrand cross-links due to its linear structure 
(depicted above B). Graphs represent an average of at least 3 experiments. Error bars 
represent standard error of the mean.  
 
 Following binding and incisions by DNA glycosylases, the next step in base 
excision repair is carried out by AP endonucleases, which are required to incise the DNA 
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backbone and release the bound glycosylases from the lesion (54, 55).  E. coli has two 
AP endonucleases, Exo III and Endo IV, encoded by xth and nfo, respectively (48).  
Similar to that seen in fpg and nth mutants, deletion of xth conferred a modest resistance 
to both angelicin and 8-methoxypsoralen-damage (Figure 3.2). By comparison, although 
inactivation of nfo did not affect the survival in in the presence of angelicin, it conferred a 
modest resistance that was specific to 8-methoxypsoralen-treatement. These observations 
suggest that base excision repair gylcosylases and AP endonucleases modestly sensitize 
cells to psoralen-induced damage.  With the exception of Endo IV, a similar sensitization 
was observed in the presence of either angelicin or 8-methoxypsoralen, suggesting that 
the pathway is acting upon the monoadduct product and not interstrand cross-links.  In 
the case of Endo IV, the data could suggest that the enzyme is specific for interacting 
with interstrand cross-links or that it may distinguish between angelicin and 8-
methoxypsoralen structures, thus only recognizing the 8-methoxypsoralen monoadduct.  
Considering that all other enzymes appear to operate on the monoadduct, we favor the 
latter interpretation, but cannot exclude the possibility that Endo IV is uniquely 
recognizing interstrand cross-links.   
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Figure 3.2. Inactivation of Endonuclease IV confers resistance to 8-methoxypsoralen-
induced damage. The survival of WT (closed squares), xth-(open squares), and nfo-(open 
triangles) deficient cells following UVA irradiation in the presence of A) 40 µg/mL 
angelicin or B) 10 µg/mL 8-methoxypsoralen. Anglicin produces monoadducts whereas 
8-methoxypsoralen produces monoadducts and DNA interstrand cross-links. Graphs 
represent an average of at least 3 experiments. Error bars represent standard error of the 
mean. 
 
 To further characterize whether base excision repair's mode of action was 
centered on the monoadduct or interstrand cross-link, we examined how the enzyme's 
presence affected the rate that these lesions were formed and incised.  We reasoned that if 
the base excision repair enzymes impede cross-link removal, then mutants lacking the 
glycosylases or AP endonucleases may incise these lesions are a faster rate.  To examine 
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the rate of cross-link incision, cultures containing plasmid pBR322 were irradiated with 
UVA in the presence of 8-methoxypsoralen and then allowed to recover. At various times 
during the two-hour recovery period aliquots of each culture were collected and total 
genomic and plasmid DNA was purified then restricted with HindIII to linearize the 
plasmid. The form of the plasmid DNA was determined by Southern analysis following 
alkali denaturing agarose electrophoresis.  Under denaturing conditions, DNA molecules 
that contain DNA interstrand cross-links are prevented from separating and can be 
detected due to their slower migration pattern relative to linear, single-stranded DNA (56, 
57). In wild type cells, over 80% of the cross-links were incised by the end of the two-
hour recovery period (Figure 3.3). By contrast, in uvrA mutants the rate of incision was 
severely impaired, with the majority of cross-links remaining unincised throughout the 
recovery period.  When we examined a mutant lacking the fpg, nth, and nei glycosylases, 
the rate of cross-link incision was not detectably different than that seen in wild type 
cells. Similarly, in cultures lacking either the Exo III or Endo IV AP endonuclease, the 
rate of cross-link incision was similar to that seen in wild type cells. Thus, the absence of 
these base excision repair gene products does not alter the rate of cross-link incision.  
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Figure 3.3. Inactivation of glycosylases or AP endonuclease activity does not alter 
incision rate of 8-methoxypsoralen cross-links from E. coli cells containing plasmid 
pBR322. A) Cultures containing pBR322 were UVA irradiated with 5.7 kJ/m2 in the 
presence of 20 µg/mL of 8-methoxypsoralen and then allowed to recover for 120 
minutes. To examine the cross-links remaining at time points during the recovery period, 
total genomic and plasmid DNA was purified from cells, restricted with HindIII to 
linearize the plasmid, and examined by Southern analysis following alkali gel 
electrophoresis using 32P-labeled pBR322 as a probe. B) The fraction of cross-links 
remaining in the DNA during the recovery period is plotted for WT (filled squares), uvrA 
(filled diamonds), fpg nth nei (open squares with X), nfo (open triangles), and xth (open 
squares). The initial percentage of cross-linked plasmids immediately following UVA 
irradiation (time 0) were WT 4.2% ± 0.7; uvrA 4.4% ± 0.5; fpg nth nei 3.0% ± 0.1; nfo 
4.5% ± 0.1; xth 4.5% ± 0.3.     
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 In addition to the rate of cross-link incision, we also monitored and compared the 
rate that cross-links were formed in wild type, excision defective uvrA, the fpg nth nei 
glycosylase mutant, and AP endonuclease mutant nfo. To this end, cultures containing the 
plasmid pBR322 were UVA-irradiated in the presence of 8-methoxypsoralen for 
increasing amounts of time.  Total DNA was purified from treated cultures at times 
indicated, linearized with HindIII, and examined by Southern analysis following alkali 
agarose gel electrophoresis. In wild type cultures, the amount of interstrand cross-links 
increased with time of irradiation with ~10% of the plasmids containing a cross-link 
following 34 kJ/m2 UVA (Figure 3.4).  By comparison, in uvrA mutants an elevated level 
of cross-links was observed at each UVA dose relative to wild type cultures, consistent 
with the idea that neither the monoadducts nor cross-links can be removed or incised, 
respectively, in these mutants. Cultures lacking Fapy, Endo III, and Endo VIII 
glycosylases displayed a rate of cross-link induction that was similar to that of wild type 
cells.  
 We also noted that in the absence of the glycosylases, a unique intermediate 
appeared which migrated progressively faster than the single cross-link product as the 
UVA dose increased. At present, we are unable to identify this intermediate. However, in 
previous work, we’ve noted a similar progressively increasing mobility of the cross-link 
band occurring at high UVA doses, after the entire population of plasmids has been 
cross-linked. We attributed this increased mobility to plasmids containing multiple cross-
links, which would limit the ability of the arms to denature, resulting in a plasmid having 
a more linear, faster migrating shape. Although the mobility is similar here, it is not clear 
why multiple cross-links would form only on a subset of the plasmids. Further, this effect 
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appears to only occur in the glycosylase mutants. Since the effect is not observed in the 
nfo-mutant, which is also hyperresistant to psoralen-induced damage, we think the multi-
cross-linked species or intermediate is unlikely to be responsible for the hyperresistance 
of the glycosylase mutant.  
 A second possibility is that this accumulating band shift represents a repair 
intermediate. A single incision of one strand may also produce a smaller product that 
migrates faster. However, this observation is not consistent with the observation that the 
species appears to progressively migrate faster as the dose increases. Further, since this 
intermediate does not appear in wild type cells or in nfo-mutants—which are also 
hyperresistant—it seems unlikely that it represents a true ‘repair’ intermediate.  
 In the AP endonuclease mutant, nfo, the rate of cross-link formation is also 
similar to that of wild type cells. The lack of effect in glycosylase incision or formation is 
interesting considering that the mutant as resistant to psoralen- but not angelicin-induced 
damage. The lack in difference of activity towards cross-links supports the idea that Endo 
IV operates on the monoadduct form of psoralen-induced damage.  
 Directly monitoring the removal or induction of monoadducts in vivo is more 
challenging than that of cross-links. Although we were not able to determine the number 
of monoadducts present in each plasmid molecule, the accumulation of monoadducts 
does appear to modestly retard the mobility of the linear plasmid. This is most apparent in 
the uvrA-mutant, where the linear plasmid band progressively shifts up as the UVA dose 
increases and more monoadducts form on the DNA molecule. In wild type cells, a similar 
but less prominent shift of the linear DNA occurs as UVA dose increases, likely 
reflecting the ability to remove the lesions during the period of irradiation, which occurs 
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over a 90-minute period (Figure 3.4A). By comparison, however, no noticeable shift 
occurred in either the nfo- or fpg nth nei-deficient cultures, suggesting that fewer 
monoadducts were forming in these mutants at each dose of UVA. In Figure 3.4C we 
quantified the decrease of the initial linear band area per UVA dose over total DNA per 
lane.  
 fpg nth nei-deficient cultures appeared to accumulate total damage at a slower rate 
than wild type cells (Figure 3.4C). Although we are unable to quantify the number of 
monoadducts required to shift the linear band, a slower rate of monoadduct formation in 
these base excision repair mutants could explain the modest resistance observed to both 
angelicin and psoralen in these mutants and suggests that the presence of these enzymes 
may impede monoadduct removal.   
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Figure 3.4. Cross-link induction in base excision repair mutants is similar to induction in 
wild type cells. A) Dose response of interstrand cross-links formation in vivo. Wild type, 
uvrA-, fpg nth nei-, and nfo-deficient cultures containing plasmid pBR322 were exposed 
to increasing doses of UVA light in the presence of 10µg/mL 8-methoxypsoralen. DNA 
from cultures was purified and analyzed as in Figure 3 to observe interstrand cross-link 
formation at each dose indicated. B) The percent of cross-linked plasmid (4.3 kB) at each 
dose is plotted per strain: WT (filled squares), uvrA (filled diamonds), fpg nth nei (open 
squares with X), and nfo (open diamonds). C) The percent linear DNA at ease dose is 
plotted per strain.  
 
Discussion 
 Here we show that glycosylase mutants fpg and nth and AP endonuclease mutant 
xth are modestly resistant in the presence of angelicin monoadducts as well as 8-
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methoxypsoralen monoadducts and cross-links compared to wild type cells. Since the 
mutants are about equally as resistant to either chemical plus UVA light, we infer that the 
sensitivity observed in presence of these gene products was due to their detrimental 
interaction with monoadducts, not cross-links. Alternatively, AP endonuclease mutant nfo 
was specifically resistant to 8-methoxypsoralen cross-links and monoadducts, which 
could mean that either the functional protein operates specifically, albeit negatively, with 
cross-links or that it interacts with 8-methoxypsoralen monoadducts but not angelicin 
monoadducts due to difference in isomer structure. Purified Fpg and Nei have both been 
shown to bind and incise monoadducts as well as an unhooked three-stranded diadduct in 
vitro (25). However, we found that neither the glycosylases or AP endonucleases altered 
the rate of cross-link incision or formation in vivo. The resistance of these mutants and 
the lack of effect on the incision rate argue against the idea that these enzymes promote 
repair of cross-links in cells. These observations, coupled with the resistance seen in 
angelicin-treated cells, support the interpretation that base excision repair proteins might 
interact specifically with monoadducted DNA.  
 Other observations that support the idea that base excision repair proteins operate 
on psoralen monoadducts can be seen in the dose curve blots of wild type, nfo-, and uvrA-
deficient cells where the linear band slowly migrates upward as UVA increases (Figure 
4A). This is more prevalent in the uvrA mutants, presumably because monoadducts are 
not incised in this strain and would cause denatured DNA to run slightly slower than 
damage-free single stranded DNA. Because this is seen in wild type cells but not in triple 
glycosylase mutants, we would propose that when these proteins are present they interact 
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with monoadduct DNA and obstruct other repair enzymes, such as those in the nucleotide 
excision repair pathway, from gaining access to the lesions to effect removal.  
 Cross-link formation by 8-methoxypsoralen and UVA light occurs in a sequence 
of steps where a molecule intercalates DNA, undergoes photoactivation of the furan ring 
with a thymine base, and then undergoes a second photoactivation of the pyrone ring with 
an adjacent thymine. Monoadducts that occur on the pyrone ring are not precursors for 
cross-linking (36, 59). As previously mentioned, Couvé et al. demonstrated that Fpg and 
Nei glycosylases are capable of excising psoralen monoadducts (24) as well as unhooked 
three-stranded diadducted oligos (25), however the substrates that these studies focused 
on were of 8-methoxypsoralen covalently bound to DNA from the molecule’s pyrone 
ring. If it were the case that one the base excision repair proteins examined here operate 
explicitly on pyrone-side adducts, then it would make sense why we did not observe a 
difference in cross-link formation in the glycosylase mutants. This is because this form of 
damage cannot be converted into a cross-link and therefore its repair would not slow 
down cross-link formation in either wild type or glycosylase-deficient cells. If these 
enzymes do operate to remove pyrone-side monoadducts in a manner that impedes 
another pathway from processing them more pragmatically, then this would agree with 
our observation that mutants survive angelicin or 8-methoxytreatment better than wild 
type cells.  
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Chapter IV: Conclusion 
 
 DNA interstrand cross-links are a highly disruptive form of damage in cells that 
induce lethality if not repaired	(1). The mechanisms of repair have been challenging to 
study but are extremely important to understand when considering the development of 
new cross-link-based chemotherapeutics (2)(3). Additionally, characterizing the cellular 
pathways involved in DNA interstrand cross-link repair could benefit future treatment of 
patients with Fanconi anemia	(4). Early cross-link repair studies in E. coli demonstrated 
that these lesions were incised from DNA in repair proficient cells but not in strains with 
defective nucleotide excision repair enzymes (5). Experiments have since been conducted 
in a variety of model systems such as yeast, Drosophila, Xenopus, and mammalian cells 
which all have shared repair mechanisms for removing cross-links but each differ in 
complexity of the pathways involved (6). Mammalian model systems have suggested the 
involvement of numerous FANC proteins—those associated with the Fanconi anemia 
pathway—as well as enzymes from multiple repair pathways but delineating the overall 
process has proven challenging to recapitulate in vivo (7)	(8). Therefore, the aim of this 
study was to provide in vivo evidence for cross-link repair following the initial incision 
steps by nucleotide excision repair by returning to experiments in E. coli—a simplified 
model organism with highly conserved repair pathways.  
 In order to accomplish this, E. coli cultures deficient in candidate repair genes 
were examined for their sensitivity to 8-methoxypsoralen+UVA-induced cross-links and 
survival capacity relative to wild type cells. Because 8-methoxypsoralen-UVA treatment 
also induces single-stranded damage, the monofunctional isomer angelicin was used to 
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compare sensitivity of mutant strains to damage induced by either chemical (9). First, 
candidates from the nucleotide excision repair pathway were examined to determine if 
the uvrD gene product would contribute to survival of cross-links. The observation that a 
uvrD mutant was nearly as resistant to 8-methoxypsoralen treatment as wild type cells 
but nearly as sensitive to angelicin treatment as uvrA mutants suggested that when 
present, the UvrD enzyme only contributes to the repair of monoadducts. To confirm this, 
the incision of cross-links from endogenous plasmids was examined via Southern blot 
analysis following UVA irradiation in the presence of 8-methoxypsoralen in wild type, 
uvrA-, and uvrD-deficient strains. Surprisingly, uvrD mutants have an impaired capacity 
for incising cross-links, just like uvrA mutants. This observation seemed to conflict with 
the survival results raising the question of how a uvrD mutant could survive similar to 
wild type cells while having a diminished to almost negligible capacity for incising cross-
links from endogenous plasmid DNA.  
 In order to resolve this conflict, an additional Southern blot analysis was 
performed to examine the rate of cross-link formation and from this determine the 
number of cross-links capable of inducing lethality in wild type cultures. It was observed 
that one cross-link per E. coli chromosome is sufficient to inactivate wild type cell 
cultures. This quantity is lower than previously reported but comports with our 
observations that nucleotide excision repair enzymes may be necessary to incise cross-
links but that this processing event does not contribute to survival in E. coli. Additionally, 
we show via survival analysis that double-strand breaks are not a predominant 
intermediate in cross-link repair and that translesion synthesis does not contribute to 
survival of cross-links. Evidence for this was that recN mutants and polBdinBumuDC 
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mutants are equally sensitive to UVA irradiation in the presence of angelicin or 8-
methoxypsoralen.  
 The final candidate pathway that was examined in this study was base excision 
repair.  Glycosylase mutants—fpg, nth, nfi, and nei—were examined as well as 
apurinic/apyrimidinic (AP) endonuclease mutants—xth and nfo—for their sensitivity to 
psoralen treatments. While none of these mutants exhibited any sensitivity relative to 
wild type cells, fpg, nth, and xth mutants exhibited resistance to both isomers of psoralen, 
suggesting that when these gene products are present they sensitize cells through 
interactions with monoadducts, not cross-links. Additionally, cells deficient in AP 
endonuclease Endo IV (nfo) exhibited resistance exclusively to UVA irradiation in the 
presence of 8-methoxypsoralen treatment. Southern blot analysis was performed to 
determine if this resistance was specific to cross-links or just the linear monoadduct 
structure of this isomer by examining if the rate of cross-link incisions was enhanced in 
the resistant mutants or if cross-links formed more slowly. In either case, mutants 
exhibited phenotypes that were indistinguishable from wild type cells. However, what did 
slightly differ in the dose curve blots was that the shift of linear, undamaged DNA was 
slower in triple glycosylase mutant—fpgnthnei—suggesting that the formation of 
monoadducts may be impeded when these gene products are absent. Additionally, a DNA 
intermediate was observed from this mutant that migrated just below the cross-link band 
and seemed to accumulate as UVA dose increased.  
 Although we were unable to characterize this intermediate, we infer that the 
structure either represents the accumulation of more cross-links or that it is an incision 
byproduct on a plasmid molecule that contains at least one cross-link. The latter seems 
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more reasonable since these mutants are associated with a greater capacity for survival 
relative to wild type cells. Furthermore, it would support the argument that the 
glycosylases operate on monoadduct structures and impede their removal by other repair 
pathways such as nucleotide excision repair. In summary, although cross-links are 
capable of being processed in wild type cells, the observation that one cross-link is 
sufficient for reducing survival of cell in cultures to 37% suggests that the repair enzymes 
involved are not capable of restoring the integrity of the DNA following damage in E. 
coli. The results that support these conclusions are summarized in Table 4.1.  
Table 4.1 Summary of in vivo results of E. coli mutants from candidate DNA interstrand 
cross-link repair pathways relative to wild type cells.  
  Results relative to wild type cells 






Angelicin                        
+ UVA 
8-methoxy-










uvrA- sensitive sensitive impaired enhanced 
uvrD- sensitive equal to WT impaired - 
Translesion 
Synthesis  
polB-          





sensitive - - 
Double-strand 
Break Repair 
recA- sensitive sensitive - - 
recN- mildly sensitive 
mildly 
sensitive - - 
Base Excision 
Repair 




WT*w nth- resistant resistant 
nei- equal to WT equal to WT 
nfi- equal to WT equal to WT - - 
xth- resistant resistant equal to WT - 
nfo- equal to WT resistant equal to WT equal to WT 
 *    triple mutant of fpg, nth, & nei was examined 	 	
w similar, with the exception of an unusal DNA intermediate 	
 
 How these findings may relate to more complex organisms such as mammals has 
not been addressed directly in the present study but is not unimaginable since the repair 
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pathways examined here are highly conserved across taxa. In humans, chromosomal 
abnormalities as observed by chromosomal breakage tests in Fanconi anemia blood 
samples indicate a clear difference between cross-link processing in these cells versus 
blood samples from non-afflicted persons (10). This does not contradict our inferences of 
minimal repair capacity in wild type cells but simply suggests that lack of repair capacity 
in Fanconi cells is far more destructive to replicated chromosomal structures than when 
cross-linking are processed, especially during replication. Furthermore, since the E. coli 
genome is ~700 times smaller than the human genome and is comprised mostly of gene-
encoding DNA it seems reasonable that human cells would have a higher capacity for 
damage from cross-links.  
 In summary, cross-links are highly lethal in E. coli and processing events appear 
to be non-productive in the traditional sense of eliciting a faithful repair mechanism.   
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